Ask The Experts

Anil Kane
Formulation & Development

Anil Kane, Ph.D., MBA

Executive Director, Global Head of Technical & Scientific Affairs

Dr. Kane has more than 25 years of experience in the science and business of taking molecules through the entire drug development process. His extensive knowledge spans early stage development to scale-up and commercial manufacturing, and includes technology transfers between global sites and life cycle management.

Publications

Anticipating the Formulation Challenges of Complex Molecules Phase Appropriate Formulation Process Design
Ask a question
Kasper van den Dries
Softgels

Kaspar van den Dries, Ph.D.

Senior Director Formulation Sciences, Solid Dosage Forms and Softgels

Dr. van den Dries leads the European R&D team in the development of innovative softgel formulations, processes and technologies. He is an expert in the formulation of poorly soluble compounds and self-emulsifying drug delivery systems with experience spanning the entire solid dosage form development cycle.

Publications

Are You Prepared for the Complexity of Pediatric Drug Development?
Ask a question
Peter Poechlauer
API (Small Molecule)

Peter Poechlauer, Ph.D.

Innovation Manager, Small Molecule API

Dr. Poechlauer possesses more than 25 years of experience in biocatalysis and oxidation chemistry. He is an expert in the application of innovative technologies, such as process intensification and microreactor flow chemistry, to small molecule API process development.

Publications

What You Need to Know to Avoid Costly Delays in Your API Scale-Up
Ask a question
Christy Eatmon
Biologics (Large Molecule)

Christy Eatmon

Senior Staff Scientist, Research & Development

Christy Eatmon provides technical support, designs strategies, and supports new business opportunities for our sterile manufacturing business. Christy has more than 14 years of experience in pharma with an emphasis on process engineering, product development, aseptic manufacturing and filling. She has working knowledge of all phases from drug discovery to sterile product commercial manufacturing with expertise in small and large molecule sterile formulation. Previously, Christy supported our Greenville, NC, site as a Senior Principal Scientist.
Ask a question
Mike Cruskie
API (Small Molecule)

Michael Cruskie, Ph.D.

Executive Director and General Manager

Dr. Cruskie has more than 20 years of experience working with small molecule APIs, ushering them from early development to scale-up and commercial manufacture. His areas of expertise include supply chain management, technology transfers, project management and business development.
Ask a question
Tony Pidgeon
Formulation & Development

Tony Pidgeon

Director, Business Management

Tony Pidgeon has nearly three decades of experience in the formulation and process development of sterile and solid products, both small molecule and biopharmaceuticals. He is an expert in exploiting the advantages of single-use manufacturing technologies.

Publications

Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs
Ask a question
Bill Weiser
API (Small Molecule)

William E. Weiser, Ph.D.

Senior Director, Pharmaceutical Development Services

Dr. Weiser is an expert in analytical method development and validation for APIs and drug products. His expertise includes stability program development, analytical method troubleshooting, preparation of the CMC Section of IND/NDA/CTD submissions, and U.S. agency for European API manufacturers.
Ask a question
Sanjay Konagurthu
Formulation & Development

Sanjay Konagurthu, Ph.D.

Senior Director, PDS Global Science and Technology

Dr. Konagurthu has more than 17 years of experience managing and assisting in the development of compounds from discovery through clinical and commercial manufacturing. He has extensive experience in oral solid dosage forms including solubility enhancement and modified release.

Publications

Strategies for API Solubility and Bioavailability Enhancement
Ask a question
Gabriel Mirko
Commercial Manufacturing

Mirko Gabriele

Production Director

An expert in scale-up and technology transfers, Mr. Gabriele’s over 10 years of pharmaceutical industry experience includes API bulk production, quality control and research and development.
Ask a question
Paul Jorjorian
Biologics (Large Molecule)

Paul Jorjorian

Vice President and General Manager of Biologics

Paul Jorjorian is an expert in the purification of biotherapeutic proteins (chromatography, filtration, viral reduction), technology transfers, viral clearance studies and process characterization (QbD/DoE). His current responsibilities include refining the integration of technology transfer processes across our global biologics network.

Publications

Top 5 Considerations When Looking to Outsource to a Biomanufacturing Partner
Ask a question
Frank Ritacco - Biologics Development & Manufacturing Expert
Biologics (Large Molecule)

Frank Ritacco, Ph.D.

Director, Scientific and Technical Affairs

Frank has a PhD in Microbiology and Molecular Genetics from Rutgers University, and 20+ years of experience in the pharma industry. Areas of expertise include mammalian cell culture, microbial fermentation, cell line development, media development and optimization, process development, scale-up, tech transfer, and clinical manufacturing. Frank oversees new technology development in the Bioprocess and manufacturing sciences, driving scientific innovation and collaboration, and serves as a technical subject matter expert, interfacing with customers and the biopharma community.
Ask a question

Contact us today to utilize our network of API and biologics experts for your upcoming development or commercial project.